SCHEMBL6561071

SCHEMBL6561071

CCCCNC(=S)N(C)C

nearest known ligand 0.83

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.47
KMT2A Q03164 3/20 0.44
HPGD P15428 1/20 0.44
ALDH1A1 P00352 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
EPHX1 P07099 4/20 0.41
MEN1 O00255 2/20 0.41
MAPT P10636 3/20 0.41
GAA P10253 2/20 0.41
HTT P42858 2/20 0.41
ALOX12 P18054 1/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
LMNA P02545 2/20 0.39
ACHE P22303 1/20 0.39
MMP2 P08253 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14617688 0.85
SCHEMBL25627141 0.82 DNM1 (0.44) L3MBTL1EPHX1
SCHEMBL7508667 0.79 CA12 (0.46) L3MBTL1KMT2AHPGDALDH1A1TDP1
SCHEMBL22400003 0.79 L3MBTL1 (0.42) L3MBTL1KMT2AHPGDALDH1A1TDP1
SCHEMBL134357 0.79 ALDH1A1 (0.50) L3MBTL1KMT2AHPGDALDH1A1TDP1
SCHEMBL10946532 0.79 CA1 (0.43) HPGDALDH1A1TDP1GAASMN1; SMN2
SCHEMBL15511328 0.77 L3MBTL1 (0.41) L3MBTL1KMT2AHPGDALDH1A1TDP1
SCHEMBL7514061 0.76 CA12 (0.55) L3MBTL1ALDH1A1EPHX1
SCHEMBL22646022 0.76 L3MBTL1 (0.35) L3MBTL1KMT2AHPGDALDH1A1TDP1
Trimethylammonium SCHEMBL15610870 0.74 CYP2C9 (0.44) L3MBTL1KMT2AHPGDALDH1A1EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4186888-A1 COMPOUND AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS ModernaTX, Inc. (US) 2023-05-31 EP disclosed
WO-2021155267-A2 MRNAS ENCODING METABOLIC REPROGRAMMING POLYPEPTIDES AND USES THEREOF MODERNATX, INC. (US) 2021-08-05 WO disclosed
WO-2021076805-A1 MRNAS ENCODING IMMUNE MODULATING POLYPEPTIDES AND USES THEREOF Moderna TX, Inc. (US) 2021-04-22 WO disclosed
WO-2021026358-A1 COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF AGENTS Moderna TX, Inc. (US) 2021-02-11 WO disclosed
WO-2021022173-A1 COMPOSITIONS AND METHODS FOR DELIVERY OF RNA INTERFERENCE AGENTS TO IMMUNE CELLS MODERNATX, INC. (US) 2021-02-04 WO disclosed
WO-2020227510-A1 POLYNUCLEOTIDES FOR DISRUPTING IMMUNE CELL ACTIVITY AND METHODS OF USE THEREOF MODERNATX, INC. (US) 2020-11-12 WO disclosed
WO-2020061367-A1 COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS MODERNATX, INC. (US) 2020-03-26 WO disclosed
WO-2019152557-A1 COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS TO IMMUNE CELLS MODERNATX, INC. (US) 2019-08-08 WO disclosed
EP-1085009-B1 INDAN DERIVATIVES NISSAN CHEMICAL IND LTD (JP) 2004-11-10 EP disclosed
EP-0934296-B1 CHROMAN DERIVATIVES NISSAN CHEMICAL IND LTD (JP) 2003-06-04 EP disclosed
US-6486178-B1 Indane derivatives NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2002-11-26 US disclosed
EP-1085009-A1 INDAN DERIVATIVES Nissan Chemical Industries, Ltd. (JP) 2001-03-21 EP disclosed
US-6066631-A Chroman derivatives NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2000-05-23 US disclosed
WO-2000012492-A1 BENZOXAZINE DERIVATIVES NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2000-03-09 WO disclosed
EP-0934296-A1 CHROMAN DERIVATIVES NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 1999-08-11 EP disclosed
WO-1998004542-A1 CHROMAN DERIVATIVES NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1998-02-05 WO disclosed
US-4199413-A TIN SALT LAYER GIVES HIGH DENSITY IMAGES MITA INDUSTRIAL COMPANY LIMITED (JP) 1980-04-22 US disclosed
US-4156735-A SALIDIURETICS HOECHST AKTIENGESELLSCHAFT (DE) 1979-05-29 US disclosed
US-4118501-A SALIDIURETIC ACTIVITY HOECHST AKTIENGESELLSCHAFT (DE) 1978-10-03 US disclosed